Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir

Por Johnson, Mark, Borland, Julie, Chen, Shuguang, Savina, Paul, Wynne, Brian, Piscitelli, Stephen
Publicado no Br J Clin Pharmacol (2014)

Effect of Fosamprenavir-Ritonavir on the Pharmacokinetics of Dolutegravir in Healthy Subjects

Por Song, Ivy, Borland, Julie, Chen, Shuguang, Peppercorn, Amanda, Wajima, Toshihiro, Piscitelli, Stephen C.
Publicado no Antimicrob Agents Chemother (2014)

antiCODE: a natural sense-antisense transcripts database

Por Yin, Yifei, Zhao, Yi, Wang, Jie, Liu, Changning, Chen, Shuguang, Chen, Runsheng, Zhao, Haitao
Publicado em 2007

Effect of Prednisone on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir

Por Song, Ivy H., Borland, Julie, Chen, Shuguang, Savina, Paul, Peppercorn, Amanda F., Piscitelli, Stephen
Publicado em 2013

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers

Por Min, Sherene, Song, Ivy, Borland, Julie, Chen, Shuguang, Lou, Yu, Fujiwara, Tamio, Piscitelli, Stephen C.
Publicado em 2010

Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir

Por Song, Ivy, Borland, Julie, Chen, Shuguang, Patel, Parul, Wajima, Toshihiro, Peppercorn, Amanda, Piscitelli, Stephen C.
Publicado em 2012

Effects of Etravirine on the Pharmacokinetics of the Integrase Inhibitor S/GSK1265744

Por Ford, Susan L., Gould, Elizabeth, Chen, Shuguang, Lou, Yu, Dumont, Etienne, Spreen, William, Piscitelli, Stephen
Publicado em 2013

Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744

Por Ford, Susan L., Gould, Elizabeth, Chen, Shuguang, Margolis, David, Spreen, William, Crauwels, Herta, Piscitelli, Stephen
Publicado em 2013

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol

Por Song, Ivy H., Borland, Julie, Chen, Shuguang, Wajima, Toshihiro, Peppercorn, Amanda F., Piscitelli, Stephen C.
Publicado no Ann Pharmacother (2015)

Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir

Por Song, Ivy, Borland, Julie, Min, Sherene, Lou, Yu, Chen, Shuguang, Patel, Parul, Wajima, Toshihiro, Piscitelli, Stephen C.
Publicado em 2011

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572

Por Song, Ivy, Borland, Julie, Chen, Shuguang, Lou, Yu, Peppercorn, Amanda, Wajima, Toshihiro, Min, Sherene, Piscitelli, Stephen C
Publicado em 2011

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects

Por Koteff, Justin, Borland, Julie, Chen, Shuguang, Song, Ivy, Peppercorn, Amanda, Koshiba, Takaaki, Cannon, Courtney, Muster, Heather, Piscitelli, Stephen C
Publicado em 2013

Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects

Por Lou, Yu, Buchanan, Ann M., Chen, Shuguang, Ford, Susan L., Gould, Elizabeth, Margolis, David, Spreen, William R., Patel, Parul
Publicado no Clin Pharmacol Drug Dev (2016)

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

Por Weller, Stephen, Borland, Julie, Chen, Shuguang, Johnson, Mark, Savina, Paul, Wynne, Brian, Wajima, Toshihiro, Peppercorn, Amanda F., Piscitelli, Stephen C.
Publicado em 2013

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma

Por Li, Guangbing, Zhang, Haohai, Wan, Xueshuai, Yang, Xiaobo, Zhu, Chengpei, Wang, Anqiang, He, Lian, Miao, Ruoyu, Chen, Shuguang, Zhao, Haitao
Publicado em 2014

Pharmacokinetics of Single-Dose Dolutegravir in HIV-Seronegative Subjects With Moderate Hepatic Impairment Compared to Healthy Matched Controls

Por Song, Ivy H, Borland, Julie, Savina, Paul M, Chen, Shuguang, Patel, Parul, Wajima, Toshihiro, Peppercorn, Amanda F, Piscitelli, Stephen C
Publicado no Clin Pharmacol Drug Dev (2013)

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects

Por Letendre, Scott L., Mills, Anthony M., Tashima, Karen T., Thomas, Deborah A., Min, Sherene S., Chen, Shuguang, Song, Ivy H., Piscitelli, Stephen C.
Publicado em 2014

Prevalent Polymorphisms in Wild-Type HIV-1 Integrase Are Unlikely To Engender Drug Resistance to Dolutegravir (S/GSK1349572)

Por Vavro, Cindy, Hasan, Samiul, Madsen, Heather, Horton, Joseph, DeAnda, Felix, Martin-Carpenter, Louise, Sato, Akihiko, Cuffe, Robert, Chen, Shuguang, Underwood, Mark, Nichols, Garrett
Publicado em 2013

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

Por Castellino, Stephen, Moss, Lee, Wagner, David, Borland, Julie, Song, Ivy, Chen, Shuguang, Lou, Yu, Min, Sherene S., Goljer, Igor, Culp, Amanda, Piscitelli, Stephen C., Savina, Paul M.
Publicado em 2013

Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir

Por Song, Ivy, Borland, Julie, Chen, Shuguang, Guta, Phyllis, Lou, Yu, Wilfret, David, Wajima, Toshihiro, Savina, Paul, Peppercorn, Amanda, Castellino, Stephen, Wagner, David, Hosking, Louise, Mosteller, Michael, Rubio, Justin P., Piscitelli, Stephen C.
Publicado em 2014